Register entry
Pharmacosmos A/S
- Registered sites
- 1
- Drug products
- 10
- Live patents
- 29
- Countries
- 1
- Base
- Denmark
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Pharmacosmos A/S | HolbaekDenmark | Active ingredient (API) manufacture, Finished drug manufacture | 3002807874 |
Exclusivity
Patents
29Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Oct 2031 |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Mar 2034 |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Dec 2034 |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Dec 2037 |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Jul 2039 |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | Nov 2040 |
| MONOFERRIC | FERRIC DERISOMALTOSE | Mar 2029 |
| MONOFERRIC | FERRIC DERISOMALTOSE | Aug 2029 |
| MONOFERRIC | FERRIC DERISOMALTOSE | Jun 2036 |
Catalogue
Marketed products
10Showing 10 of 10.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| COSELA | trilaciclib | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| - | Dextran | POWDER | BULK INGREDIENT |
| - | Dextran | POWDER | BULK INGREDIENT |
| - | Dextran | POWDER | BULK INGREDIENT |
| - | Dextran 1 | POWDER | DRUG FOR FURTHER PROCESSING |
| - | Dextran 60 | POWDER | DRUG FOR FURTHER PROCESSING |
| - | Dextran 70 | POWDER | DRUG FOR FURTHER PROCESSING |
| Monoferric | Ferric derisomaltose | INJECTION, SOLUTION | NDA |
| Monoferric | Ferric derisomaltose | INJECTION, SOLUTION | NDA |
| Monoferric | Ferric derisomaltose | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.